Kringle Pharma,Inc. (4884) — research page
JP · jp-cm-kg/TSE-GROWTH/4884 · as of 2026-11-06
Identity and listing
Kringle Pharma,Inc. is listed on the Growth Market under ticker 4884. Its ISIN is not on the record, and neither is its LEI. Its security type is Corporate, its segment is not on the record, its sector is 3250 Pharmaceutical, and its jurisdiction is Japan (EDINET domestic filer). Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Kringle Pharma,Inc. | source · 2026-11-06 |
| exchange | Growth Market | source · 2026-11-06 |
| ticker | 4884 | source · 2026-11-06 |
| ISIN | not on the record | |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-06 |
| segment | not on the record | |
| sector | 3250 Pharmaceutical | source · 2026-11-06 |
| jurisdiction | Japan (EDINET domestic filer) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 7 filings in the twelve months to 2026-11-06, across 4 filing days. The median gap between filing days is 112 days. The record date is 67 days after the latest filing, which was an ad hoc filing dated 2026-08-31. The Growth Market median cadence gap is 42 days across 598 issuers, and its median latency is 85.0 days. The 3250 Pharmaceutical sector median cadence gap is 49.5 days across 80 issuers, and its median latency is 85.0 days. The issuer's median cadence gap is above both medians, and its latency is below both.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 7 | 112 | 67 |
| exchange median: Growth Market (598 issuers) | 8 | 42 | 85 |
| sector median: 3250 Pharmaceutical (80 issuers) | 8 | 49.5 | 85 |
| date | type | category | filing |
|---|---|---|---|
| 2026-08-31 | ad_hoc | 臨時報告書 (extraordinary report) | 臨時報告書 |
| 2026-05-11 | results | 半期報告書 (half-year report) | 半期報告書－第25期(2025/10/01－2026/09/30) |
| 2026-05-11 | regulatory_filing | 135 | 確認書 |
| 2025-12-24 | ad_hoc | 臨時報告書 (extraordinary report) | 臨時報告書 |
| 2025-12-19 | results | 有価証券報告書 (annual securities report) | 有価証券報告書－第24期(2024/10/01－2025/09/30) |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is EY新日本有限責任監査法人. Its location is not on the record. Auditor changes are not on the record.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, because no lifecycle type map exists for this register yet. The issuer is listed and not halted.
Orderability
For Qualified Institutional Investors, the signal is null and the outcome is not determinable. The subject's class carries no CFI to place on the scope bridge, and no scope object names the class, so the subject is not shown within the scope. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.
| client category | outcome |
|---|---|
| Qualified Institutional Investors | not determinable: the rule states a product scope; the subject's class carries no CFI to place on the scope bridge, and no scope object names the class: the subject is not shown within the scope |
rule acm-68000/jp/suitability-principle-fiea-article-40/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were named on the issuer's investor-relations page, and none was found on the pages read. The count is 0.
Open research
The record holds 3 openly published research notes. Shared Research Inc. published on 2023-03-31 and 2023-01-06, and The Stock Research Center published on 2021-01-07.
| date | publisher | note | kind |
|---|---|---|---|
| 2023-03-31 | Shared Research Inc. | Full Report for the Three Months Ended December 31, 2022 | issuer-sponsored |
| 2023-01-06 | Shared Research Inc. | Full Report for the Fiscal Year Ending September 30, 2022 | issuer-sponsored |
| 2021-01-07 | The Stock Research Center | Kringle Pharma（4884-TSE Mothers）Newly Listed Company Introduction Report | independent |
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed, so no sealed years hold the issuer and no earliest sealed date exists. The live record for the issuer has not begun in any sealed form.
Sources
9 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)
- 10.2
- https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)
- 10.3
- https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4884 (the disclosure lines)
- 10.4
- https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)
- 10.5
- https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XBJD (the auditor)
- 10.6
- https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.7
- https://sharedresearch.jp/en/companies/4884#top (open research)
- 10.8
- https://holistic-r.org/adm/wp-content/uploads/2020/12/4884201229_en.pdf (open research)
- 10.9
- https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4884 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"ticker":"4884","exchange":"Growth Market"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:596f65879283212d.